Africa’s COVID Vaccine Roll-Out Depends On Restoring Other Vaccination Programs 27/11/2020 Paul Adepoju Africa’s COVID-19 rollout is anticipated for Spring 2021, despite the continent’s low vaccine preparedness, multiple health leaders in Africa have said, as policy advisory groups flag the importance that other successful immunization campaigns will have on COVID recovery. At a press briefing on Thursday, Dr. John Nkengasong, Director of Africa CDC, said: “Africa may have […] Continue reading -> Combating The Shadow Pandemic Of Violence Against Women 27/11/2020 Raisa Santos Violence against women and girls has been neglected during and worsened by the COVID-19 pandemic, and urgent efforts are needed to protect women, UNAIDS has said. One in three women likely to experience violence at least once in their lifetime. Evidence indicates that the COVID-19 pandemic has resulted in significant increases in gender-based violence in […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Hurricanes And Holidays Set To Worsen COVID In The Americas 26/11/2020 Raisa Santos New York City. The pandemic has been exacerbated by recent hurricanes in Central America, as a result of outbreaks in overcrowded emergency shelters, as well as travel during the American Thanksgiving season, health leaders said at a Pan American Health Organization (PAHO) press conference. Last week, saw an increase of 1.5 million cases reported in […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Climate Change Is An Existential Threat To Health: Diverse Global Health Leaders & Politicians Echo Growing Sentiment 25/11/2020 Paul Adepoju ‘Planetary health’ describes how the limits of natural resources like clean air, water and food production shape our long-term health, with climate change as a “threat-multiplier” for future COVID-19 like crises. Experts at the Geneva Health Forum explored the links, ahead of next week’s launch of the 2020 Lancet Countdown Report on Health and Climate […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Combating The Shadow Pandemic Of Violence Against Women 27/11/2020 Raisa Santos Violence against women and girls has been neglected during and worsened by the COVID-19 pandemic, and urgent efforts are needed to protect women, UNAIDS has said. One in three women likely to experience violence at least once in their lifetime. Evidence indicates that the COVID-19 pandemic has resulted in significant increases in gender-based violence in […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Hurricanes And Holidays Set To Worsen COVID In The Americas 26/11/2020 Raisa Santos New York City. The pandemic has been exacerbated by recent hurricanes in Central America, as a result of outbreaks in overcrowded emergency shelters, as well as travel during the American Thanksgiving season, health leaders said at a Pan American Health Organization (PAHO) press conference. Last week, saw an increase of 1.5 million cases reported in […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Climate Change Is An Existential Threat To Health: Diverse Global Health Leaders & Politicians Echo Growing Sentiment 25/11/2020 Paul Adepoju ‘Planetary health’ describes how the limits of natural resources like clean air, water and food production shape our long-term health, with climate change as a “threat-multiplier” for future COVID-19 like crises. Experts at the Geneva Health Forum explored the links, ahead of next week’s launch of the 2020 Lancet Countdown Report on Health and Climate […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Hurricanes And Holidays Set To Worsen COVID In The Americas 26/11/2020 Raisa Santos New York City. The pandemic has been exacerbated by recent hurricanes in Central America, as a result of outbreaks in overcrowded emergency shelters, as well as travel during the American Thanksgiving season, health leaders said at a Pan American Health Organization (PAHO) press conference. Last week, saw an increase of 1.5 million cases reported in […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Climate Change Is An Existential Threat To Health: Diverse Global Health Leaders & Politicians Echo Growing Sentiment 25/11/2020 Paul Adepoju ‘Planetary health’ describes how the limits of natural resources like clean air, water and food production shape our long-term health, with climate change as a “threat-multiplier” for future COVID-19 like crises. Experts at the Geneva Health Forum explored the links, ahead of next week’s launch of the 2020 Lancet Countdown Report on Health and Climate […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Hurricanes And Holidays Set To Worsen COVID In The Americas 26/11/2020 Raisa Santos New York City. The pandemic has been exacerbated by recent hurricanes in Central America, as a result of outbreaks in overcrowded emergency shelters, as well as travel during the American Thanksgiving season, health leaders said at a Pan American Health Organization (PAHO) press conference. Last week, saw an increase of 1.5 million cases reported in […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Climate Change Is An Existential Threat To Health: Diverse Global Health Leaders & Politicians Echo Growing Sentiment 25/11/2020 Paul Adepoju ‘Planetary health’ describes how the limits of natural resources like clean air, water and food production shape our long-term health, with climate change as a “threat-multiplier” for future COVID-19 like crises. Experts at the Geneva Health Forum explored the links, ahead of next week’s launch of the 2020 Lancet Countdown Report on Health and Climate […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Climate Change Is An Existential Threat To Health: Diverse Global Health Leaders & Politicians Echo Growing Sentiment 25/11/2020 Paul Adepoju ‘Planetary health’ describes how the limits of natural resources like clean air, water and food production shape our long-term health, with climate change as a “threat-multiplier” for future COVID-19 like crises. Experts at the Geneva Health Forum explored the links, ahead of next week’s launch of the 2020 Lancet Countdown Report on Health and Climate […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Climate Change Is An Existential Threat To Health: Diverse Global Health Leaders & Politicians Echo Growing Sentiment 25/11/2020 Paul Adepoju ‘Planetary health’ describes how the limits of natural resources like clean air, water and food production shape our long-term health, with climate change as a “threat-multiplier” for future COVID-19 like crises. Experts at the Geneva Health Forum explored the links, ahead of next week’s launch of the 2020 Lancet Countdown Report on Health and Climate […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> Posts navigation Older postsNewer posts